Who is sponsoring NCT04582032?

NCT04582032 is sponsored by Ankara City Hospital Bilkent.

What drugs are being tested in NCT04582032?

Interventions in NCT04582032: Dexketoprofen (KETAVEL 50 mg/2 ml), Saline (Isotonic Saline Solution 0.9% ).

What condition does NCT04582032 study?

NCT04582032 studies Injection Site Irritation.

Is NCT04582032 still recruiting?

NCT04582032 is currently completed. Last updated 29 January 2021.

Last reviewed 2021-01-29 · How we verify

NCT04582032

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain

Completed NA Last updated 29 January 2021

What this trial tests

NA trial testing Dexketoprofen (KETAVEL 50 mg/2 ml) in Injection Site Irritation in 68 participants. Completed in 4 January 2021.

Timeline

1 November 2020

Primary endpoint
4 December 2020

4 January 2021

Quick facts

Lead sponsor	Ankara City Hospital Bilkent
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	68
Start date	1 November 2020
Primary completion	4 December 2020
Estimated completion	4 January 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Dexketoprofen (KETAVEL 50 mg/2 ml) — full drug profile →
Saline (Isotonic Saline Solution 0.9% ) — full drug profile →

Conditions studied

Injection Site Irritation — all drugs for Injection Site Irritation →

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 18 to 60, any sex, with Injection Site Irritation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose : The aim of the study is to investigate the effects of cox inhibitors as a rescue agent against the rocuronium pain Methodology : Sixty patients enrolled for the general anesthesia enrolled in this study. Patients were allocated into two groups (Group 1: Dexketoprofen group, Group 2: Control group) .Pain was evaluated by during rocuronium injection, patients were scored by a scale showed below. 0;No movement response to injection 1. Mild movement response to injection 2. Hand withdrawal response to injection 3. Arm withdrawal response to injection Investigators also evaluated the pain with 2 questions when the patient was in the recovery room. Question 1.What was the last feeling before participants fall into sleep? question 2. Did participants feel any pain on participants's hand during medication injection for anesthesia?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexketoprofen (KETAVEL 50 mg/2 ml)

Trials testing the same drug.

NCT06954896 — Comparison of Superior Hypogastric Plexus Block and Peritoneal Bupivacaine in Pain Management · completed
NCT06932367 — The Efficacy of Dexketoprofen And Methylprednisolone in the Acute Low Back Pain · Phase 4 · completed

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04582032 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
Last refreshed: 29 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04582032.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing